CRT-200.05 High On-treatment Platelet Reactivity to Aspirin and Clopidogrel Increases the Risk of Cardiovascular Events in Patients with Critical Limb Ischemia

Wesley Ghasem,Noor Al-Asady,Joshua Perese,Jorge Caro,David Shavelle,Ray V Matthews,Vincent Rowe,Leonardo Clavijo

doi:10.1016/j.jcin.2018.01.090

CRT-200.05 High On-treatment Platelet Reactivity to Aspirin and Clopidogrel Increases the Risk of Cardiovascular Events in Patients with Critical Limb Ischemia

Wesley Ghasem, Noor Al-Asady + Show 6 more

Open Access

https://doi.org/10.1016/j.jcin.2018.01.090

Copy DOI

Journal: JACC: Cardiovascular Interventions	Publication Date: Feb 1, 2018
License type: publisher-specific-oa

#High On-treatment Platelet Reactivity #Risk Of Cardiovascular Events + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Critical limb ischemia (CLI) is associated with increased risk of adverse cardiovascular and limb events. This study aims to determine if high on-treatment platelet reactivity (HPR) to aspirin (HPRA) and/or clopidogrel (HPRC) is associated with increased risk of adverse cardiovascular or limb events

Full Text